We are live on ! Find out more
TECH icon

Bio-Techne

271 hedge funds and large institutions have $3.72B invested in Bio-Techne in 2017 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 114 increasing their positions, 93 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more call options, than puts

Call options by funds: $732K | Put options by funds: $559K

23% more repeat investments, than reductions

Existing positions increased: 114 | Existing positions reduced: 93

6.1% more ownership

Funds ownership: 385.97%392.07% (+6.1%)

0% more capital invested

Capital invested by funds: $3.7B → $3.72B (+$15.8M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

4% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 25

4% less funds holding

Funds holding: 281271 (-10)

Holders
271
Holders Change
-10
Holders Change %
-3.56%
% of All Funds
6.75%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
24
Increased
114
Reduced
93
Closed
25
Calls
$732K
Puts
$559K
Net Calls
+$173K
Net Calls Change
+$173K

TECH Hedge Fund Activity: Q1 2017 in Review

271 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q1 2017, worth a combined $3.72B — up 0.43% from $3.7B a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of TECH and 24 opened new positions — a net loss of 1 holder — while 93 trimmed existing stakes and 114 added.

The largest buyer was BlackRock, adding an estimated $359M. The largest seller was Columbia Wanger Asset Management, cutting an estimated $35.7M.

  • 271 institutional investors held Bio-Techne (TECH) as of Q1 2017, down from 281 in Q4 2016.
  • Funds reported $3.72B of Bio-Techne stock for Q1 2017, up 0.43% quarter-over-quarter.
  • 24 funds opened new Bio-Techne positions in Q1 2017 and 25 closed out, a net change of -1 holder.
  • The largest Bio-Techne buyer in Q1 2017 was BlackRock, an estimated $359M added.
  • The largest Bio-Techne seller in Q1 2017 was Columbia Wanger Asset Management, an estimated $35.7M sold.

Based on aggregated 13F filings for Q1 2017.